Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride 62756-0915
Product NDC
62756-0915- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- September 29, 2012
- Listing Expires
- December 31, 2026
- Application
- ANDA090922
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cetirizine Hydrochloride | 5 mg/1 |
| Pseudoephedrine Hydrochloride | 120 mg/1 |
Drug Class
Adrenergic alpha-Agonists [MoA]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(2)
2 BLISTER PACK in 1 CARTON (62756-915-62) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (62756-915-60)
4 BLISTER PACK in 1 CARTON (62756-915-73) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (62756-915-60)
External Resources